All of the following statements are true regarding warfarin toxicity (skin necrosis) except:
Skin necrosis occurs during initiation of therapy Most common sites are toes and tips of fingers Decreased quantity of protein C Decreased incidence of adverse effects if therapy with LMWH is started.